Full video transcriptClick to expand
Auto-generated transcript of @kmartfit's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00If you're on TRT and have high hematocrit, try this.
- 0:02The most common thing that happens with guys on TRT or not on TRT is they go in dehydrated
- 0:07to the blood test.
- 0:08They show elevated levels of red blood cell count, hematocrit and hemoglobin.
- 0:11You gotta be drinking 64 ounces of water before you get a blood test done in order to show
- 0:16accurate levels of red blood cell count, hematocrit and hemoglobin.
- 0:19Try this on your next blood test and see what happens.
High hematocrit on TRT: what actually works and what doesn't
Quick answer
Testosterone therapy is a known driver of erythrocytosis through erythropoietin stimulation and hepcidin suppression, producing true increases in red blood cell mass distinct from the relative erythrocytosis seen with dehydration. Hematocrit above 54 percent on TRT warrants clinical evaluation and potential dose adjustment, not hydration-based retesting as a primary strategy. Patients with persistently elevated hematocrit should consult their prescribing provider about dose, frequency, or delivery method changes before assuming lab artifact.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 4 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For High hematocrit on TRT: what actually works and what doesn't, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
High hematocrit on TRT: what actually works and what doesn't is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "High hematocrit on TRT: what actually works and what doesn't" from KMART. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Testosterone therapy is a known driver of erythrocytosis through erythropoietin stimulation and hepcidin suppression, producing true increases in red blood cell mass distinct from the relative erythrocytosis seen with dehydration.
The reason this review is not generic is the source wording and the canonical claim label "trt how to fix high hematocrit on testosterone replacement thera." In this clip, the useful excerpt is: "If you're on TRT and have high hematocrit, try this." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Testosterone therapy is a known driver of erythrocytosis through erythropoietin stimulation and hepcidin suppression, producing true increases in red blood cell mass distinct from the relative erythrocytosis seen with dehydration.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone therapy is a known driver of erythrocytosis through erythropoietin stimulation and hepcidin suppression, producing true increases in red blood cell mass distinct from the relative erythrocytosis seen with dehydration. Hematocrit above 54 percent on TRT warrants clinical evaluation and potential dose adjustment, not hydration-based retesting as a primary strategy. Patients with persistently elevated hematocrit should consult their prescribing provider about dose, frequency, or delivery method changes before assuming lab artifact.
- Dehydration does cause relative erythrocytosis by reducing plasma volume, making hematocrit readings falsely high. This is a real pre-analytical variable, not a myth.
- Testosterone therapy also causes true erythrocytosis by stimulating erythropoietin production and suppressing hepcidin. Bachman et al. (2014, JCEM) showed dose-dependent hematocrit increases in men on testosterone.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Dehydration does cause relative erythrocytosis by reducing plasma volume, making hematocrit readings falsely high. This is a real pre-analytical variable, not a myth.
- Testosterone therapy also causes true erythrocytosis by stimulating erythropoietin production and suppressing hepcidin. Bachman et al. (2014, JCEM) showed dose-dependent hematocrit increases in men on testosterone.
- The specific 64-ounce hydration recommendation has no cited clinical source. Labs vary in their pre-draw hydration guidance and no universal standard supports this number.
- Hematocrit above 54 percent on TRT is a threshold for clinical concern. Guo et al. (2023, Journal of the American Heart Association) linked elevated hematocrit in testosterone users to increased adverse cardiovascular events.
- If hematocrit is borderline and hydration at the time of the draw is uncertain, repeating the test well-hydrated is reasonable. If it's consistently elevated across multiple draws, that requires clinical management.
- Clinical options for testosterone-induced erythrocytosis include dose reduction, more frequent smaller injections, switching to a transdermal formulation, or therapeutic phlebotomy. These are prescriber decisions, not self-managed fixes.
- Framing hydration as a fix for high hematocrit on TRT is misleading at scale. For men with true testosterone-driven polycythemia, acting on this advice instead of seeking clinical guidance carries real cardiovascular risk.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @kmartfit actually say?
The claim is straightforward: if you're on TRT and getting high hematocrit readings, you might just be showing up to the lab dehydrated. @kmartfit says "you gotta be drinking 64 ounces of water before you get a blood test done" to get accurate red blood cell, hematocrit, and hemoglobin numbers. He frames this as a fix, or at least a diagnostic step, before assuming your TRT is actually causing the elevation.
To be fair, he's not saying hydration cures polycythemia. He's saying dehydration can produce a false positive, and that you should rule it out first. That's a narrower, more defensible claim. But the way it's packaged, as a solution to high hematocrit rather than a troubleshooting step, matters a lot when 72,000 people are watching.
Does the science back this up?
Partially, yes. Dehydration genuinely can concentrate blood and produce falsely elevated hematocrit readings. This is not controversial. The problem is that the 64-ounce number is pulled from thin air, and the framing buries a more serious issue.
Hematocrit is a percentage measurement of red blood cells relative to total blood volume. When you're dehydrated, plasma volume drops, so the ratio shifts upward even if your actual red blood cell count hasn't changed. This is called relative erythrocytosis, and it's real. A 2019 review by Caglar et al. in the International Journal of Laboratory Hematology confirmed that pre-analytical variables including hydration status meaningfully affect hematocrit results. Labs generally recommend adequate hydration before blood draws for this reason.
However, testosterone therapy also causes true, absolute erythrocytosis by stimulating erythropoietin production and suppressing hepcidin, which increases iron availability for red blood cell synthesis. This is well-documented. Bachman et al. (2014, Journal of Clinical Endocrinology and Metabolism) found testosterone dose-dependently increased hematocrit in healthy men. Drinking water will not fix that.
What did they get wrong (or right)?
He got the mechanism right but the framing wrong, and that gap is clinically meaningful.
Credit where it's due: dehydration as a confounding variable in hematocrit readings is legitimate and underappreciated. Many men do show up to fasted morning labs without adequate hydration, which can inflate numbers. Checking hydration status before assuming TRT is the culprit is reasonable advice.
But calling this a way to "fix" high hematocrit is misleading. If your hematocrit is running 52-54 percent on TRT, you are not dehydrated. You have testosterone-induced erythrocytosis, and no amount of water addresses that. The actual clinical management of persistent high hematocrit on TRT includes dose reduction, changing injection frequency, switching delivery method, or therapeutic phlebotomy. None of that was mentioned.
There's also no clinical basis for the specific 64-ounce figure. Standard pre-draw hydration recommendations vary by lab and context. Presenting a specific number as fact without a source is the kind of thing that sounds authoritative and isn't.
What should you actually know?
High hematocrit on TRT is one of the more clinically significant side effects of testosterone therapy, and it deserves more than a hydration hack.
Testosterone increases red blood cell production through multiple pathways. Hematocrit above 54 percent is generally considered a threshold for clinical concern because of increased blood viscosity and associated cardiovascular risk, including stroke and thromboembolism. A 2023 analysis by Guo et al. in the Journal of the American Heart Association found elevated hematocrit was associated with increased adverse cardiovascular events in men on testosterone therapy.
If your hematocrit is borderline and you're unsure about your hydration status at the time of the draw, yes, repeat the test well-hydrated. That's sensible. But if you're getting consistently elevated readings across multiple draws, that is a conversation for your prescribing clinician, not a TikTok fix. Dose adjustments, injection frequency changes, and in some cases phlebotomy are the actual tools here. Hydration is a pre-analytical control, not a treatment.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
KMART · TikTok creator
72.1K views on this video
How to fix high Hematocrit on Testosterone Replacement Therapy TRT #Trt #trtgains #trt101 #trtfamily #trttransformation #trtshots #trtshot #trtforlife #trtdays #trtcommunity #trtbeforeandafter #trtlife #trtgainz #trtformen #trtworld #trtnation #lowt #testosterone #testosteronelevels #testosteroneinjection #testosteronecypionate #testosteronegains #testosteronetherapy #testosteroneboosters #testosteroneshots #testosteroneshot #testosteroneshottime #testosteronehealth #testosteroneforme
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about dehydration does cause relative erythrocytosis by reducing plasma volume, making?
Dehydration does cause relative erythrocytosis by reducing plasma volume, making hematocrit readings falsely high. This is a real pre-analytical variable, not a myth.
What does the video say about testosterone therapy also causes true erythrocytosis by stimulating erythropoietin production?
Testosterone therapy also causes true erythrocytosis by stimulating erythropoietin production and suppressing hepcidin. Bachman et al. (2014, JCEM) showed dose-dependent hematocrit increases in men on testosterone.
What does the video say about the specific 64-ounce hydration recommendation has no cited clinical source.?
The specific 64-ounce hydration recommendation has no cited clinical source. Labs vary in their pre-draw hydration guidance and no universal standard supports this number.
What does the video say about hematocrit above 54 percent on trt?
Hematocrit above 54 percent on TRT is a threshold for clinical concern. Guo et al. (2023, Journal of the American Heart Association) linked elevated hematocrit in testosterone users to increased adverse cardiovascular events.
What does the video say about if hematocrit?
If hematocrit is borderline and hydration at the time of the draw is uncertain, repeating the test well-hydrated is reasonable. If it's consistently elevated across multiple draws, that requires clinical management.
What does the video say about clinical options for testosterone-induced erythrocytosis include dose reduction, more frequent?
Clinical options for testosterone-induced erythrocytosis include dose reduction, more frequent smaller injections, switching to a transdermal formulation, or therapeutic phlebotomy. These are prescriber decisions, not self-managed fixes.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by KMART, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.